Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Forum on the Diagnosis, Evaluation, and Management of Zika Virus Infection among Infants

Wednesday and Thursday August 30-31, 2017

Series of photos showing infants, women, and doctors

The Centers for Disease and Control and Prevention (CDC) is hosting a Forum in collaboration with the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. This Forum will be an opportunity to convene experts to review emerging evidence and collect individual input regarding the diagnosis, evaluation and management of infants with possible congenital Zika virus (Zika) infection.

Specific objectives include

  • Review emerging data to inform the evaluation and care of infants with possible congenital Zika infection
  • Identify strategies to use prenatal ultrasound and amniocentesis to inform the diagnosis and clinical management of infants with congenital Zika syndrome
  • Identify strategies that optimize communication between providers caring for an infant with congenital Zika exposure
  • Explore strategies to enhance coordination of care and transfer of health information from obstetric providers to the pediatrician at the systems-level for infants with possible congenital Zika exposure

Pregnant women in the United States, DC, and US territories have laboratory evidence of Zika virus infection. Infants with birth defects have been born to women with laboratory evidence of Zika infection during pregnancy in the United States. In August 2016, CDC released Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection. Since that time, new information has become available and recently, CDC updated its interim guidance for healthcare providers caring for pregnant women with possible Zika exposure, which has implications for the guidance related to care and management of infants. As such, CDC is reviewing the new data to determine the appropriate care and support needed to care for these vulnerable infants and families.

During this Forum, pediatric specialists, obstetric specialists, non-governmental partners, and federal officials will gather at CDC and experts will provide individual input regarding the clinical evaluation and management of congenitally exposed and infected infants in the United States. CDC will collect this input, which will help inform potential future updates to the guidance for the clinical evaluation and management of infants and can inform strategies for communication and coordination of care.

Opening sessions on Wednesday, August 30, from 8:30-11:30AM ET will be available via webcast on this webpage. Closing sessions on Thursday, August 31, from 12:30-3:00PM ET will be available via one-way (listen-only) teleconference. Instructions for both sessions and the Forum agenda are below.

Agenda [PDF – 3 pages]

If you have questions before or after the Forum, email

Webcast Instructions

The general sessions describing the state of the science will be live webcast on Wednesday morning;

August 30: 8:30 – 11:30 AM ET

Due to firewall concerns, some users may need to cut and paste the link into their internet browser.

Please Note: The links below are to be used the day and time of the event only. Also note that that the links are not secure.

Stream #1—No Captions:

Stream #2—With Captions:

Call-In Instructions

The expert input that emerges from Wednesday and Thursday’s sessions will be discussed on Thursday afternoon.

August 31: 12:30 – 3:00 PM ET

To listen to this closing session, a one-way (listen-only) call-in line will be available. To join by phone, call

  • (404) 553-8912 or (855) 348-8390

When prompted, enter conference ID: 392784. No questions will be taken from callers, but callers can email for responses to their inquiries.

Please Note: The phone numbers and conference ID are to be used the day and time of the event only.

Technical Support

For technical support, call 1-404-639-3737.